Insider trades

Otis W. Brawley, Director of Lyell Immunopharma LYEL, has filed 1 purchase and 0 sales on the open market. The latest trade was on 06/10.

Otis W. Brawley

Director
First filing
23/03/20
Trades
26 trades
Buys / sales
1 / 0
12-month net buying
No record
Last trade
06/10

Trading activity

Transactions

Trade type
Open-market buy25/03/3125/04/0235,640 sh$0.56$19,958.4No record